article Utilising an interleukin-12 plasmid: a novel COVID-19 vaccine 13 May 2020 | By Victoria Rees (Drug Target Review) Dr Bernard Fox from Providence Cancer Institute explains how OncoSec’s CORVax12 vaccine works to potentially combat COVID-19.